FTC Demands Info on Drug Mega-Merger

When Merck(MRK Quote) announced its game-changing plan to acquire Schering-Plough(SGP Quote) for $41.1 billion in cash and stock, regulatory issues on the path to closing were bound to raise an eyebrow.

No doubt, since the two companies will combine to make the world's second largest drugmaker.

Thus, it's no surprise to us that the two said they received requests from the Federal Trade Commission for additional information about their proposed merger based on antitrust law. And it was apparentely no surprise to them: The two drug manufacturers said in a release on Monday that they expected the request and plan to cooperate fully with it. ...